JP2021532838A5 - - Google Patents

Info

Publication number
JP2021532838A5
JP2021532838A5 JP2021532503A JP2021532503A JP2021532838A5 JP 2021532838 A5 JP2021532838 A5 JP 2021532838A5 JP 2021532503 A JP2021532503 A JP 2021532503A JP 2021532503 A JP2021532503 A JP 2021532503A JP 2021532838 A5 JP2021532838 A5 JP 2021532838A5
Authority
JP
Japan
Prior art keywords
seq
purified
galnac
solution
galactosaminidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021532503A
Other languages
English (en)
Japanese (ja)
Other versions
JP7684216B2 (ja
JP2021532838A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2019/051121 external-priority patent/WO2020034043A1/en
Publication of JP2021532838A publication Critical patent/JP2021532838A/ja
Publication of JP2021532838A5 publication Critical patent/JP2021532838A5/ja
Priority to JP2025081746A priority Critical patent/JP2025131609A/ja
Application granted granted Critical
Publication of JP7684216B2 publication Critical patent/JP7684216B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021532503A 2018-08-17 2019-08-16 ドナー臓器における糖鎖抗原除去のための酵素組成物、それに関連する方法および使用 Active JP7684216B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025081746A JP2025131609A (ja) 2018-08-17 2025-05-15 ドナー臓器における糖鎖抗原除去のための酵素組成物、それに関連する方法および使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862719272P 2018-08-17 2018-08-17
US62/719,272 2018-08-17
PCT/CA2019/051121 WO2020034043A1 (en) 2018-08-17 2019-08-16 Enzymatic compositions for carbohydrate antigen cleavage on donor organs, methods and uses associated therewith

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025081746A Division JP2025131609A (ja) 2018-08-17 2025-05-15 ドナー臓器における糖鎖抗原除去のための酵素組成物、それに関連する方法および使用

Publications (3)

Publication Number Publication Date
JP2021532838A JP2021532838A (ja) 2021-12-02
JP2021532838A5 true JP2021532838A5 (enExample) 2022-08-23
JP7684216B2 JP7684216B2 (ja) 2025-05-27

Family

ID=69524510

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2021532503A Active JP7684216B2 (ja) 2018-08-17 2019-08-16 ドナー臓器における糖鎖抗原除去のための酵素組成物、それに関連する方法および使用
JP2021507883A Active JP7570316B2 (ja) 2018-08-17 2019-08-16 糖鎖抗原除去のための酵素組成物、それに関連する方法、使用、装置およびシステム
JP2024111653A Pending JP2024163994A (ja) 2018-08-17 2024-07-11 糖鎖抗原除去のための酵素組成物、それに関連する方法、使用、装置およびシステム
JP2025081746A Pending JP2025131609A (ja) 2018-08-17 2025-05-15 ドナー臓器における糖鎖抗原除去のための酵素組成物、それに関連する方法および使用

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2021507883A Active JP7570316B2 (ja) 2018-08-17 2019-08-16 糖鎖抗原除去のための酵素組成物、それに関連する方法、使用、装置およびシステム
JP2024111653A Pending JP2024163994A (ja) 2018-08-17 2024-07-11 糖鎖抗原除去のための酵素組成物、それに関連する方法、使用、装置およびシステム
JP2025081746A Pending JP2025131609A (ja) 2018-08-17 2025-05-15 ドナー臓器における糖鎖抗原除去のための酵素組成物、それに関連する方法および使用

Country Status (8)

Country Link
US (4) US20210324361A1 (enExample)
EP (2) EP3837370A4 (enExample)
JP (4) JP7684216B2 (enExample)
CN (4) CN112839512B (enExample)
AU (1) AU2019322933B2 (enExample)
BR (1) BR112021002899A2 (enExample)
CA (2) CA3109723A1 (enExample)
WO (2) WO2020034043A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116024183B (zh) * 2023-02-15 2023-10-31 中国农业科学院兰州兽医研究所 一种用于荧光染色的重组蓝舌病毒及其构建方法
WO2025213250A1 (en) * 2024-04-11 2025-10-16 The University Of British Columbia Enzymatic compositions for b antigen cleavage, methods, uses, apparatuses and systems associated therewith
JP2026057100A (ja) 2024-09-20 2026-04-02 トヨタ自動車株式会社 電気ユニット

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4609627A (en) * 1983-08-01 1986-09-02 New York Blood Center, Inc. Enzymatic conversion of certain sub-type A and AB erythrocytes
CA2272925A1 (en) * 1996-11-21 1998-05-28 Jack Goldstein Method for conversion of blood type
US7767415B2 (en) * 2001-09-25 2010-08-03 Velico Medical, Inc. Compositions and methods for modifying blood cell carbohydrates
WO2007053565A2 (en) 2005-10-31 2007-05-10 Zymequest, Inc. Novel a-galactosidases
WO2007100294A1 (en) * 2006-02-28 2007-09-07 Kurt Nilsson Material system for blood products
CA2697999C (en) * 2009-04-24 2013-04-30 Werner Hoelke A stabilized aqueous alpha-galactosidase composition and methods relating thereto
JP6336392B2 (ja) 2012-09-08 2018-06-06 株式会社オーガンテクノロジーズ 移植のための臓器又は組織の長期維持方法
CA2920293A1 (en) 2013-08-16 2015-02-19 Alexion Pharmaceuticals, Inc. Treatment of graft rejection by administering a complement inhibitor to an organ prior to transplant
CN107298699B (zh) * 2017-07-21 2020-09-11 天津大学 通过添加大分子拥挤试剂高效体外生物生产蛋白质的配方及方法
EP3962295A1 (en) * 2019-05-01 2022-03-09 The Procter & Gamble Company Probiotic bacterial strains that produce short chain fatty acids and compositions comprising same

Similar Documents

Publication Publication Date Title
JP2021532838A5 (enExample)
US5830741A (en) Composition for tissue dissociation containing collagenase I and II from clostridium histolyticum and a neutral protease
US20200060260A1 (en) Compositions and methods for organ preservation
Kim et al. Sperm penetration through cumulus mass and zona pellucida.
JP2020505934A (ja) 異常ヘモグロビン症の治療用組成物及び方法
Zhou et al. Human progenitor cells with high aldehyde dehydrogenase activity efficiently engraft into damaged liver in a novel model
Franzin et al. Renal delivery of pharmacologic agents during machine perfusion to prevent ischaemia-reperfusion injury: from murine model to clinical trials
US20220017865A1 (en) Therapeutic gene editing for elane-associated disease
TW202246494A (zh) 基因改造肝細胞群
RU2396748C2 (ru) Среда для хранения клеток
JP2021533783A5 (enExample)
CN101792734B (zh) 胰岛的分离方法
Dial et al. Modulation of 125I-insulin degradation by receptors in liver plasma membranes
Hesse et al. Experience with 3, 6, and 24 hours' hypothermic storage of the canine pancreas before islet cell preparation and transplantation
WO2001092481A1 (en) Method of preparing small hepatocytes preservable in freeze-dried state and method of preserving the same in freeze-dried state
Tatsumi et al. Successful in vivo propagation of factor IX-producing hepatocytes in mice: potential for cell-based therapy in haemophilia B
US4533636A (en) Medium for plant protoplast culture
Hosgood et al. Current basic research in normothermic machine perfusion
Sun et al. Towards the production of universal blood by structure‐guided directed evolution of glycoside hydrolases
Atta Hepatocyte transplantation
Ogawa et al. The purification and properties of trehalase from lady beetle, Harmonia axyridis
JP7349136B2 (ja) 機能性ペプチドの絹糸への結合法
Brooks The isolation of epithelial cells from the rat epididymis
JP2012029623A (ja) 細胞分離用酵素溶液及び細胞分離方法、並びに膵島分離方法
Pizarro et al. Cold storage of liver microorgans in ViaSpan® and BG35 solutions. Study of ammonia metabolism during normothermic reoxygenation